Cargando…
Switching from Intravitreal Ranibizumab to Bevacizumab for Age-Related Macular Degeneration
Purpose. To report our experiences in patients with age-related macular degeneration (AMD) treated initially with intravitreal ranibizumab and then switched to bevacizumab. Methods. We retrospectively reviewed the records of 7 patients (7 eyes) who were treated with monthly injections of intravitrea...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912580/ https://www.ncbi.nlm.nih.gov/pubmed/24555120 http://dx.doi.org/10.5402/2011/916789 |